Literature DB >> 17245715

Antibody response to influenza vaccine in adults vaccinated with identical vaccine strains in consecutive years.

Shigeki Nabeshima1, Kenichiro Kashiwagi, Masayuki Murata, Yoko Kanamoto, Norihiro Furusyo, Jun Hayashi.   

Abstract

Fifty seven hospital workers received influenza vaccine in November 2003, and the serum HI antibody titer was determined before, 2 and 4 weeks after the vaccination. Thirty seven were vaccinated in November, 2002 consecutively (the repeated vaccination group), and the remaining 20 had not been vaccinated in the previous year (the single vaccination group). Six of the repeated vaccination group received both influenza and hepatitis B vaccination in September, 2004 and the antibody responses were examined 2 weeks later. Two and four weeks after the 2003-vaccination, the HI antibody titers to A/H1N1, A/H3N2, and B in the repeated vaccination group were significantly lower than in the single vaccination group (P < 0.05). This phenomenon had no relation to the pre-vaccination HI antibody titer. The antibody response was low to repeated influenza vaccination, but normal to hepatitis B vaccine in six subjects who had a second vaccination in 2004, showing that this depressed response was influenza-specific. These results suggest that the decreased HI antibody response to repeated influenza vaccination was affected mainly by the previous vaccination per se rather than by the pre-existing antibody titer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17245715     DOI: 10.1002/jmv.20801

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  19 in total

1.  Effects of prior influenza virus vaccination on maternal antibody responses: Implications for achieving protection in the newborns.

Authors:  Lisa M Christian; Chloe Beverly; Amanda M Mitchell; Erik Karlsson; Kyle Porter; Stacey Schultz-Cherry; Octavio Ramilo
Journal:  Vaccine       Date:  2017-08-01       Impact factor: 3.641

2.  Trivalent influenza vaccine-induced antibody response to circulating influenza a (H3N2) viruses in 2010/11 and 2011/12 seasons.

Authors:  Satoshi Hiroi; Saeko Morikawa; Keiko Nakata; Akiko Maeda; Tsuneji Kanno; Shin Irie; Satoko Ohfuji; Yoshio Hirota; Tetsuo Kase
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Comparison of immunogenicity between intradermal and intramuscular injections of repeated annual identical influenza virus strains post-pandemic (2011-2012) in COPD patients.

Authors:  Benjamas Chuaychoo; Uraiwan Kositanont; Parichat Niyomthong; Nuttapol Rittayamai; Sorachai Srisuma; Kanokwan Rattanasaengloet; Walaiporn Wongsrisakunkaew; Julalux Thongam; Thaweesak Songserm
Journal:  Hum Vaccin Immunother       Date:  2019-11-26       Impact factor: 3.452

4.  A 21-winter seasons retrospective study of antibody response after influenza vaccination in elderly (60-85 years old) and very elderly (>85 years old) institutionalized subjects.

Authors:  Emilia Nunzi; Anna Maria Iorio; Barbara Camilloni
Journal:  Hum Vaccin Immunother       Date:  2017-09-18       Impact factor: 3.452

5.  Immunogenicity, boostability, and sustainability of the immune response after vaccination against Influenza A virus (H1N1) 2009 in a healthy population.

Authors:  Elisabeth Huijskens; John Rossen; Paul Mulder; Ruud van Beek; Hennie van Vugt; Johannes Verbakel; Guus Rimmelzwaan; Marion Koopmans; Marcel Peeters
Journal:  Clin Vaccine Immunol       Date:  2011-07-27

Review 6.  Challenges of Making Effective Influenza Vaccines.

Authors:  Sigrid Gouma; Elizabeth M Anderson; Scott E Hensley
Journal:  Annu Rev Virol       Date:  2020-05-11       Impact factor: 10.431

7.  Comparison of Human H3N2 Antibody Responses Elicited by Egg-Based, Cell-Based, and Recombinant Protein-Based Influenza Vaccines During the 2017-2018 Season.

Authors:  Sigrid Gouma; Seth J Zost; Kaela Parkhouse; Angela Branche; David J Topham; Sarah Cobey; Scott E Hensley
Journal:  Clin Infect Dis       Date:  2020-09-12       Impact factor: 9.079

8.  Dose-sparing H5N1 A/Indonesia/05/2005 pre-pandemic influenza vaccine in adults and elderly adults: a phase III, placebo-controlled, randomized study.

Authors:  Joanne M Langley; George Risi; Michael Caldwell; Larry Gilderman; Bruce Berwald; Charles Fogarty; Terry Poling; Dennis Riff; Mira Baron; Louise Frenette; Eric Sheldon; Harry Collins; Marc Shepard; Marc Dionne; Daniel Brune; Linda Ferguson; David Vaughn; Ping Li; Louis Fries
Journal:  J Infect Dis       Date:  2011-06-15       Impact factor: 5.226

9.  A historically-controlled Phase III study in adults to characterize the acceptability of a process change for manufacturing inactivated quadrivalent influenza vaccine.

Authors:  Varsha K Jain; Vijayalakshmi Chandrasekaran; Long Wang; Ping Li; Aixue Liu; Bruce L Innis
Journal:  BMC Infect Dis       Date:  2014-03-10       Impact factor: 3.090

10.  The effect of age and recent influenza vaccination history on the immunogenicity and efficacy of 2009-10 seasonal trivalent inactivated influenza vaccination in children.

Authors:  Sophia Ng; Dennis K M Ip; Vicky J Fang; Kwok-Hung Chan; Susan S Chiu; Gabriel M Leung; J S Malik Peiris; Benjamin J Cowling
Journal:  PLoS One       Date:  2013-03-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.